ClinicalTrials.Veeva

Menu

Perception and Prevalence of Fungal Infections in Berlin - Brandenburg (IFI_ICU)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Invasive Mycosis

Study type

Observational

Funder types

Other

Identifiers

NCT01393002
IFI_ICU

Details and patient eligibility

About

This is a structured web-based survey in selected hospitals with intensive care units in Berlin- Brandenburg that will focus on the analysis of current knowledge in ICUs in the field of invasive mycoses.

Full description

Intensive care patients with invasive mycosis require a special clinical expertise especially in light of a high lethality. Early identification of patients at risk to develop a fungal infection is of utmost importance to start effective antifungal therapy. The implementation of current knowledge into clinical practice to fight fungal infection is not clear.

Enrollment

25 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intensive care units of hospitals in the INABBRA alliance.
  • Patients with invasive mycosis.

Exclusion criteria

  • Hospitals without intensive care unit.

Trial design

25 participants in 1 patient group

INABBRA
Description:
Participating hospitals in the INABBRA alliance.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems